Representative Lisa C. McClain of Michigan recently sold shares of Baxter International Inc. (NYSE:BAX), according to a filing made public on September 12. The transaction, which involved a sale of shares valued between $1,001 and $15,000, occurred on August 4, 2025, in her Charles Schwab brokerage account.
In addition to the Baxter shares, McClain’s recent trading activity includes selling shares of Taiwan Semiconductor Manufacturing (NYSE:TSM) valued between $50,001 and $100,000 on August 28, 2025, and purchasing shares in various companies, including ACI Worldwide (NASDAQ:ACIW) and HCA Healthcare (NYSE:HCA), both on August 19, 2025, with each purchase also falling within the $1,001 to $15,000 range.
Baxter International’s Financial Performance
On the stock market, shares of Baxter International opened at $23.88 on the day of the report. The company currently holds a market capitalization of $12.27 billion and has been experiencing fluctuations, with a 12-month low of $21.33 and a high of $40.49. Its price-to-earnings (P/E) ratio stands at -79.60, and the company has a debt-to-equity ratio of 1.30.
Baxter reported its quarterly earnings on July 31, revealing an earnings per share (EPS) of $0.59, which fell short of analysts’ expectations of $0.60. The company’s revenue for the quarter was $2.81 billion, slightly below the projected $2.82 billion. Despite these results, Baxter’s revenue showed a year-over-year increase of 4.3%. Looking ahead, Baxter has set guidance for Q3 2025 at an EPS range of 0.580 to 0.620 and for the full year 2025 at 2.420 to 2.520.
Dividend Announcement and Analyst Ratings
Baxter International also announced a quarterly dividend of $0.17 per share, which will be paid on October 1, 2025, to investors who were on record as of August 29, 2025. This dividend reflects an annualized total of $0.68 and provides a yield of 2.8%. Notably, the company’s payout ratio is currently at -226.67%, indicating a potential concern regarding its sustainability.
Wall Street analysts have recently revised their ratings on Baxter shares. Wells Fargo & Company lowered its target price from $33.00 to $24.00, while UBS Group also reduced its price objective from $35.00 to $24.00. Other firms, such as Evercore ISI and Barclays, adjusted their target prices to $42.00 and $36.00, respectively. Currently, the average rating for Baxter International is “Hold,” with a price target of $30.11, according to MarketBeat.com.
As of the latest data, institutional investors have a significant presence in Baxter, with hedge funds holding over 90.19% of the stock. Notable transactions include Mufg Securities Americas Inc. acquiring a position valued at approximately $220,000 in the fourth quarter and Public Employees Retirement System of Ohio purchasing shares worth $5,102,000.
Representative McClain, who assumed office on January 3, 2023, is also running for re-election in the upcoming 2026 election. She represents Michigan’s 9th Congressional District and has a background in business administration, having founded the North End Support Team.
Baxter International, through its various subsidiaries, develops a comprehensive range of healthcare products, operating in segments such as Medical Products, Pharmaceuticals, and Kidney Care. With an extensive portfolio, the company plays a vital role in the healthcare sector.